Multihance and Ergocalciferol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Multihance (gadobenate dimeglumine) and Ergocalciferol (ergocalciferol). Common drug interactions include pregnancy among females and hypoaesthesia among males.

The phase IV clinical study analyzes what interactions people have when they take Multihance and Ergocalciferol. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Multihance?

Multihance has active ingredients of gadobenate dimeglumine. eHealthMe is studying from 5,786 Multihance users. Check the latest studies of Multihance.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.

On Aug, 05, 2026

19 people who take Multihance and Ergocalciferol together, and have interactions are studied.

Multihance and Ergocalciferol drug interactions.

What are the common drug interactions of Multihance and Ergocalciferol, by gender? *:

female:

Pregnancy
Skin discolouration (change of skin colour)
Skin disorder (skin disease)
Skin hypertrophy (skin cells enlarges)
Abortion spontaneous (naturally occurring miscarriage)
Fistula (an abnormal connection or passageway between two)
Burning sensation
Dysphonia (speech disorder attributable to a disorder of phonation)
Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
Henoch-schonlein purpura (inflammation of the blood vessels in the skin and other body organs)

male:

Hypoaesthesia (reduced sense of touch or sensation)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Erythema (redness of the skin)
Pleural fibrosis (formation of fibrous tissue in lung)
Rash
Scleroderma (hard skin)
Skin plaque (red, scaly patches to appear on the skin)
Subcutaneous nodule
Oedema peripheral (superficial swelling)
Peau d'orange (orange peel skin)

What are the common drug interactions of Multihance and Ergocalciferol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Henoch-schonlein purpura (inflammation of the blood vessels in the skin and other body organs)

20-29:

n/a

30-39:

n/a

40-49:

Fistula (an abnormal connection or passageway between two)

50-59:

Arthralgia (joint pain)
Erythema (redness of the skin)
Gait disturbance
Hypoaesthesia (reduced sense of touch or sensation)
Mobility decreased (ability to move is reduced)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Pleural fibrosis (formation of fibrous tissue in lung)
Rash

60+:

Pain
Skin hypertrophy (skin cells enlarges)
Myalgia (muscle pain)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema peripheral (superficial swelling)
Palpitations (feelings or sensations that your heart is pounding or racing)
Peau d'orange (orange peel skin)
Post inflammatory pigmentation change
Rash
Skin discolouration (change of skin colour)

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 5 people, 26.32%
Pain: 4 people, 21.05%
Infection: 3 people, 15.79%
Menopause (end of monthly cycles in women): 3 people, 15.79%
Blood Potassium Decreased: 3 people, 15.79%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 15.79%
Diabetes: 3 people, 15.79%
Feeling Of Relaxation: 3 people, 15.79%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.79%
Vitamin B12 Deficiency: 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take Multihance and Ergocalciferol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously